Medirom Healthcare Technologies Inc. Issues ¥400 Million Convertible Bonds

Reuters12-12
Medirom Healthcare Technologies Inc. Issues ¥400 Million Convertible Bonds

Medirom Healthcare Technologies Inc. has announced the issuance of its Third Unsecured Convertible-Type Corporate Bonds with Share Options, raising a total of JPY 400,000,000. The bonds, issued in denominations of JPY 10,000,000 each, will accrue interest at 2.0% per annum and mature on June 30, 2026, with the possibility of an extension to December 25, 2026. Bond holders have the option to convert the bonds into common shares at a conversion price of JPY 343 per share between December 12, 2025, and June 10, 2026. The offering was conducted through a third-party allotment to 11 investors and is being sold outside the United States under Regulation S.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medirom Healthcare Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-120394), on December 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment